pre-IPO PHARMA

COMPANY OVERVIEW

Carisma Therapeutics Inc. is biopharmaceutical company developing a differentiated cell therapy platform focused on engineered macrophages. The first applications of the platform are autologous chimeric antigen receptor macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA


LOCATION

  • Philadelphia, PA, USA
  • Philadelphia, PA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://carismatx.com


    CAREER WEBSITE

    https://carismatx.com/careers/


    SOCIAL MEDIA


    INVESTORS

    abbvie-ventures agent-capital grazia-equity healthcap ip-group mrl-ventures-fund penn-medicine tpg-biotech wellington-partners


    PRESS RELEASES


    Nov 11, 2022

    Carisma Therapeutics Announces Clinical and Pre-Clinical Updates


    Nov 1, 2022

    Carisma Therapeutics Announces Multiple Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 37th Anniversary Annual Meeting


    Oct 26, 2022

    Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences


    Jun 27, 2022

    Steven Kelly, President and CEO of Carisma Therapeutics, Named Ernst and Young Entrepreneur of the Year 2022 Greater Philadelphia


    May 26, 2022

    Carisma Therapeutics to Present Latest Data from Phase 1 Clinical Trial of Engineered Macrophage Therapy at 2022 ASCO Annual Meeting


    For More Press Releases


    Google Analytics Alternative